Dr Kevin Fenix 

Kevin joined the Surgical Science Research Group as a research officer in July 2017. In July 2018 he was awarded an Early Career Fellowship from The Hospital Research Foundation. He is currently a research fellow with the Surgical Science Research Group and the ENT Surgery group.

With direct links to The Queen Elizabeth Hospital, my research utilises both patient samples and clinically relevant in vitro and in vivo models for translational immunology research related to cancer. As part of the Surgical Science Research Group and ENT Surgery Research Group, I have access to patient samples from gastrointestinal and head and neck cancers.

My research focuses on:

• Identifying distinct tumour-infiltrating immune cells with prognostic capacity for cancer metastasis and patient survival.
• Characterizing novel tumour-infiltrating immune cell subsets by advanced proteomic and transcriptomic approaches.
• Understanding how immune cells shape tumour progression.
• Developing T cell-based therapies for cancer.
• Understanding and exploiting the tumour microbiome to develop new cancer treatments.

Potential honours and higher degree by research students can contact me to discuss possible research projects.

Kevin completed his PhD research under the supervision of Professor Shaun McColl at the School of Biological Sciences, The University of Adelaide and was awarded a Dean’s Commendation for Doctoral Thesis Excellence in 2017.

• UoA: Kevin Fenix